Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of 373.78 million as of July 11, 2025. Its market cap has decreased by -78.51% in one year.

Market Cap

373.78M

Enterprise Value

422.30M

Revenue

643.42M

Ranking

n/a

PE Ratio

n/a

Stock Price

5.47

Market Cap Chart

Since October 6, 1995, Myriad Genetics's market cap has increased from 110.60M to 373.78M, an increase of 237.96%. That is a compound annual growth rate of 4.17%.

Market Cap History

Date	Market Cap	% Change
Jul 9, 2025	388.18M	-61.06%
Dec 31, 2024	996.94M	-25.18%
Dec 29, 2023	1.33B	36.53%
Dec 30, 2022	975.86M	-40.05%
Dec 31, 2021	1.63B	49.42%
Dec 31, 2020	1.09B	-28.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	158.45B
GSK plc	56.46B
Haleon	33.35B
Smith & Nephew	9.70B
ConvaTec Group	5.35B
Hikma Pharmaceuticals	4.37B
HUTCHMED (China)	1.93B
Indivior	1.43B

Market Cap Rankings